We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Thermo Fisher Scientific and Symphogen announced the extension of a strategic collaboration to deliver characterization and quality control workflows for the simplified analysis of complex therapeutic proteins to advance biopharmaceutical discovery and ..
Thermo Fisher Scientific and Symphogen, an affiliate of Servier, have extended a strategic collaboration to deliver innovative characterization and quality control workflows for the simplified analysis of complex therapeutic proteins to advance ...
French pharmaceutical company Servier has signed a definitive agreement to acquire 100% shares in Danish therapeutic antibody discovery firm Symphogen.